231 related articles for article (PubMed ID: 19147543)
61. Measurement of 3-acetyl-11-keto-beta-boswellic acid and 11-keto-beta-boswellic acid in Boswellia serrata Supplements Administered to Dogs.
Miscioscia E; Shmalberg J; Scott KC
BMC Vet Res; 2019 Aug; 15(1):270. PubMed ID: 31370899
[TBL] [Abstract][Full Text] [Related]
62. Platelet factor 4 induces cell apoptosis by inhibition of STAT3 via up-regulation of SOCS3 expression in multiple myeloma.
Liang P; Cheng SH; Cheng CK; Lau KM; Lin SY; Chow EY; Chan NP; Ip RK; Wong RS; Ng MH
Haematologica; 2013 Feb; 98(2):288-95. PubMed ID: 22929979
[TBL] [Abstract][Full Text] [Related]
63. Abnormal repression of SHP-1, SHP-2 and SOCS-1 transcription sustains the activation of the JAK/STAT3 pathway and the progression of the disease in multiple myeloma.
Beldi-Ferchiou A; Skouri N; Ben Ali C; Safra I; Abdelkefi A; Ladeb S; Mrad K; Ben Othman T; Ben Ahmed M
PLoS One; 2017; 12(4):e0174835. PubMed ID: 28369102
[TBL] [Abstract][Full Text] [Related]
64. Verbascoside Inhibits Glioblastoma Cell Proliferation, Migration and Invasion While Promoting Apoptosis Through Upregulation of Protein Tyrosine Phosphatase SHP-1 and Inhibition of STAT3 Phosphorylation.
Jia WQ; Wang ZT; Zou MM; Lin JH; Li YH; Zhang L; Xu RX
Cell Physiol Biochem; 2018; 47(5):1871-1882. PubMed ID: 29961065
[TBL] [Abstract][Full Text] [Related]
65. Analysis of signal transducer and activator of transcription 3 (Stat 3) pathway in multiple myeloma: Stat 3 activation and cyclin D1 dysregulation are mutually exclusive events.
Quintanilla-Martinez L; Kremer M; Specht K; Calzada-Wack J; Nathrath M; Schaich R; Höfler H; Fend F
Am J Pathol; 2003 May; 162(5):1449-61. PubMed ID: 12707028
[TBL] [Abstract][Full Text] [Related]
66. A derivative of epigallocatechin-3-gallate induces apoptosis via SHP-1-mediated suppression of BCR-ABL and STAT3 signalling in chronic myelogenous leukaemia.
Jung JH; Yun M; Choo EJ; Kim SH; Jeong MS; Jung DB; Lee H; Kim EO; Kato N; Kim B; Srivastava SK; Kaihatsu K; Kim SH
Br J Pharmacol; 2015 Jul; 172(14):3565-78. PubMed ID: 25825203
[TBL] [Abstract][Full Text] [Related]
67. Decursin chemosensitizes human multiple myeloma cells through inhibition of STAT3 signaling pathway.
Kim HJ; Kim SM; Park KR; Jang HJ; Na YS; Ahn KS; Kim SH; Ahn KS
Cancer Lett; 2011 Feb; 301(1):29-37. PubMed ID: 21122982
[TBL] [Abstract][Full Text] [Related]
68. Novel imidazopyridine suppresses STAT3 activation by targeting SHP-1.
Su JC; Chang CH; Wu SH; Shiau CW
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1248-1255. PubMed ID: 30261753
[TBL] [Abstract][Full Text] [Related]
69. Boswellic acids reduce Th17 differentiation via blockade of IL-1β-mediated IRAK1 signaling.
Stürner KH; Verse N; Yousef S; Martin R; Sospedra M
Eur J Immunol; 2014 Apr; 44(4):1200-12. PubMed ID: 24469975
[TBL] [Abstract][Full Text] [Related]
70. Arctigenin enhances chemosensitivity of cancer cells to cisplatin through inhibition of the STAT3 signaling pathway.
Yao X; Zhu F; Zhao Z; Liu C; Luo L; Yin Z
J Cell Biochem; 2011 Oct; 112(10):2837-49. PubMed ID: 21608020
[TBL] [Abstract][Full Text] [Related]
71. Constitutive activation of STAT3 in Sézary syndrome is independent of SHP-1.
McKenzie RC; Jones CL; Tosi I; Caesar JA; Whittaker SJ; Mitchell TJ
Leukemia; 2012 Feb; 26(2):323-31. PubMed ID: 21818116
[TBL] [Abstract][Full Text] [Related]
72. The tyrosine kinase inhibitor nintedanib activates SHP-1 and induces apoptosis in triple-negative breast cancer cells.
Liu CY; Huang TT; Chu PY; Huang CT; Lee CH; Wang WL; Lau KY; Tsai WC; Chao TI; Su JC; Chen MH; Shiau CW; Tseng LM; Chen KF
Exp Mol Med; 2017 Aug; 49(8):e366. PubMed ID: 28798401
[TBL] [Abstract][Full Text] [Related]
73. Reversal of the multidrug resistance of human ileocecal adenocarcinoma cells by acetyl-11-keto-β-boswellic acid via downregulation of P-glycoprotein signals.
Xue X; Chen F; Liu A; Sun D; Wu J; Kong F; Luan Y; Qu X; Wang R
Biosci Trends; 2016 Nov; 10(5):392-399. PubMed ID: 27545217
[TBL] [Abstract][Full Text] [Related]
74. Antitumorigenic effect of plumbagin by induction of SH2-containing protein tyrosine phosphatase 1 in human gastric cancer cells.
Joo MK; Park JJ; Kim SH; Yoo HS; Lee BJ; Chun HJ; Lee SW; Bak YT
Int J Oncol; 2015; 46(6):2380-8. PubMed ID: 25815436
[TBL] [Abstract][Full Text] [Related]
75. Acetyl-11-Keto-β-Boswellic Acid Promotes Osteoblast Differentiation by Inhibiting Tumor Necrosis Factor-α and Nuclear Factor-κB Activity.
Bai F; Chen X; Yang H; Xu HG
J Craniofac Surg; 2018 Oct; 29(7):1996-2002. PubMed ID: 29927820
[TBL] [Abstract][Full Text] [Related]
76. Mechanisms underlying somatostatin receptor 2 down-regulation of vascular endothelial growth factor expression in response to hypoxia in mouse retinal explants.
Mei S; Cammalleri M; Azara D; Casini G; Bagnoli P; Dal Monte M
J Pathol; 2012 Feb; 226(3):519-33. PubMed ID: 21960021
[TBL] [Abstract][Full Text] [Related]
77. Arsenic trioxide attenuates STAT-3 activity and epithelial-mesenchymal transition through induction of SHP-1 in gastric cancer cells.
Kim SH; Yoo HS; Joo MK; Kim T; Park JJ; Lee BJ; Chun HJ; Lee SW; Bak YT
BMC Cancer; 2018 Feb; 18(1):150. PubMed ID: 29409467
[TBL] [Abstract][Full Text] [Related]
78. LY294002 enhances boswellic acid-induced apoptosis in colon cancer cells.
Liu JJ; Duan RD
Anticancer Res; 2009 Aug; 29(8):2987-91. PubMed ID: 19661305
[TBL] [Abstract][Full Text] [Related]
79. Acetyl-11-keto-β-boswellic acid suppresses invasion of pancreatic cancer cells through the downregulation of CXCR4 chemokine receptor expression.
Park B; Sung B; Yadav VR; Cho SG; Liu M; Aggarwal BB
Int J Cancer; 2011 Jul; 129(1):23-33. PubMed ID: 21448932
[TBL] [Abstract][Full Text] [Related]
80. Acetyl-keto-beta-boswellic acid inhibits cellular proliferation through a p21-dependent pathway in colon cancer cells.
Liu JJ; Huang B; Hooi SC
Br J Pharmacol; 2006 Aug; 148(8):1099-107. PubMed ID: 16783403
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
